3.50
前日終値:
$3.48
開ける:
$3.46
24時間の取引高:
54,985
Relative Volume:
0.11
時価総額:
$55.64M
収益:
-
当期純損益:
$-23.87M
株価収益率:
-0.1779
EPS:
-19.67
ネットキャッシュフロー:
$-47.63M
1週間 パフォーマンス:
+1.45%
1か月 パフォーマンス:
-6.91%
6か月 パフォーマンス:
+17.06%
1年 パフォーマンス:
+1.16%
Polypid Ltd Stock (PYPD) Company Profile
PYPD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
PYPD
Polypid Ltd
|
3.50 | 55.80M | 0 | -23.87M | -47.63M | -19.67 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Polypid Ltd Stock (PYPD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-05 | 開始されました | Roth Capital | Buy |
2025-06-02 | 再開されました | H.C. Wainwright | Buy |
2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
2021-09-14 | 開始されました | JMP Securities | Mkt Outperform |
2021-07-30 | 開始されました | Cantor Fitzgerald | Overweight |
2020-11-24 | アップグレード | Raymond James | Outperform → Strong Buy |
2020-08-10 | 開始されました | Alliance Global Partners | Buy |
2020-07-21 | 開始されました | BMO Capital Markets | Outperform |
2020-07-21 | 開始されました | Barclays | Overweight |
2020-07-21 | 開始されました | Raymond James | Outperform |
すべてを表示
Polypid Ltd (PYPD) 最新ニュース
Will PolyPid Ltd. Sustain Its Chart Breakout2025 Stock Rankings & High Conviction Buy Zone Alerts - thegnnews.com
PolyPid Appoints New Chief Medical Officer Amid Strategic Advancements - MSN
Will PolyPid Ltd. Reverse From Oversold ConditionsQuarterly Performance Summary & Weekly Setup with High ROI Potential - classian.co.kr
Risk adjusted return profile for PolyPid Ltd. analyzedStock Surge & Stock Portfolio Risk Control - Newser
Pattern recognition hints at PolyPid Ltd. upsideJuly 2025 News Drivers & Daily Profit Maximizing Tips - Newser
Does PolyPid Ltd. qualify in momentum factor screeningInflation Watch & Low Risk High Win Rate Stock Picks - Newser
What high frequency data says about PolyPid Ltd.Weekly Risk Summary & Reliable Intraday Trade Alerts - Newser
Does PolyPid Ltd. fit your quant trading modelEarnings Performance Report & Fast Entry Momentum Trade Alerts - Newser
Short interest data insights for PolyPid Ltd.Earnings Overview Summary & Advanced Technical Signal Analysis - Newser
Will PolyPid Ltd. benefit from macro trendsWeekly Profit Recap & AI Optimized Trade Strategies - Newser
Can technical indicators confirm PolyPid Ltd.’s reversalGDP Growth & Safe Capital Growth Tips - Newser
What’s the recovery path for long term holders of PolyPid Ltd.2025 Price Targets & Precise Trade Entry Recommendations - Newser
Forecasting PolyPid Ltd. price range with options dataJuly 2025 Earnings & Daily Market Momentum Tracking - Newser
Live market analysis of PolyPid Ltd.Gap Down & Free Real-Time Volume Trigger Notifications - Newser
Will breakout in PolyPid Ltd. lead to full recoveryAnalyst Downgrade & Risk Controlled Daily Plans - Newser
Machine Learning Models Forecast PolyPid Ltd. UptickWeekly Market Report & Risk Controlled Stock Pick Alerts - newsyoung.net
How institutional ownership impacts PolyPid Ltd. stockVolume Spike & Daily Momentum Trading Reports - Newser
Roth Capital Has Negative Outlook for PolyPid Q3 Earnings - Defense World
Detecting price anomalies in PolyPid Ltd. with AIGap Down & Comprehensive Market Scan Insights - Newser
Sector ETF performance correlation with PolyPid Ltd.July 2025 Short Interest & Fast Moving Stock Watchlists - Newser
Can PolyPid Ltd. lead its sector in growthWeekly Earnings Recap & Target Return Focused Picks - classian.co.kr
Is PolyPid Ltd. forming a breakout patternQuarterly Profit Summary & Daily Stock Momentum Reports - classian.co.kr
Custom watchlist performance reports with PolyPid Ltd.2025 Top Decliners & Daily Risk Controlled Trade Plans - Newser
Developing predictive dashboards with PolyPid Ltd. dataMarket Sentiment Review & Long-Term Safe Return Strategies - Newser
PolyPid Ltd. stock volume spike explainedWeekly Market Outlook & Free Weekly Watchlist of Top Performers - Newser
PolyPid (NASDAQ:PYPD) Rating Lowered to “Sell” at Wall Street Zen - Defense World
HC Wainwright Has Negative Outlook for PolyPid Q3 Earnings - Defense World
PolyPid Ltd. Company Revenue and Profit Trends: A Deep DiveAnalyst Upgrade & Safe Entry Zone Tips - Newser
Why PolyPid Ltd. stock attracts strong analyst attentionSell Signal & Safe Entry Trade Reports - Newser
Polypid Ltd (PYPD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):